121 related articles for article (PubMed ID: 38689460)
1. Clinical and histopathological factors for recurrence and metastasis in lacrimal gland adenoid cystic carcinoma in Chinese patients.
Zhou X; Feng Y; Yang Y; Zong C; Yu Y; Zhu T; Shi J; Jia R; Chen H; Li Y; Song X
Eur J Ophthalmol; 2024 Apr; ():11206721241249503. PubMed ID: 38689460
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for local recurrence and survival and impact of local treatments on survival in lacrimal gland carcinoma.
Ford JR; Rubin ML; Frank SJ; Ning J; Debnam JM; Bell D; El-Naggar A; Ferrarotto R; Esmaeli B
Br J Ophthalmol; 2021 Jun; 105(6):768-774. PubMed ID: 32680839
[TBL] [Abstract][Full Text] [Related]
3. American Joint Committee on Cancer classification predicts outcome of patients with lacrimal gland adenoid cystic carcinoma.
Ahmad SM; Esmaeli B; Williams M; Nguyen J; Fay A; Woog J; Selvadurai D; Rootman J; Weis E; Selva D; McNab A; DeAngelis D; Calle A; Lopez A
Ophthalmology; 2009 Jun; 116(6):1210-5. PubMed ID: 19395039
[TBL] [Abstract][Full Text] [Related]
4. Multimodal therapy in the management of lacrimal gland adenoid cystic carcinoma.
Yang J; Zhou C; Wang Y; Fan X; Jia R
BMC Ophthalmol; 2019 Jun; 19(1):125. PubMed ID: 31176360
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Intra-arterial Cytoreductive Chemotherapy Improves Outcomes in Lacrimal Gland Adenoid Cystic Carcinoma.
Costa PA; Tse DT; Benedetto P
Oncologist; 2024 Mar; 29(3):263-269. PubMed ID: 38227581
[TBL] [Abstract][Full Text] [Related]
6. Association of T and N Categories of the American Joint Commission on Cancer, 8th Edition, With Metastasis and Survival in Patients With Orbital Sarcoma.
Sa HS; Rubin ML; Ning J; Li W; Tetzlaff MT; McGovern SL; Paulino AC; Herzog CE; Gill JB; Esmaeli B
JAMA Ophthalmol; 2020 Apr; 138(4):374-381. PubMed ID: 32105303
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Intra-Arterial Cytoreductive Chemotherapy for Lacrimal Gland Adenoid Cystic Carcinoma: A Long-Term Follow-up Study of a Trimodal Strategy.
Tse DT; Benedetto PW; Tse BC; Feuer WJ
Am J Ophthalmol; 2022 Aug; 240():239-251. PubMed ID: 35381201
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) and hypoxia inducible factor-1 alpha (HIF-1ɑ) in lacrimal gland Adenoid cystic carcinoma: Correlation with clinical outcome.
Anjum S; Sen S; Chosdol K; Bakhshi S; Kashyap S; Pushker N; Bajaj MS; Meel R; Sharma MC
Ann Diagn Pathol; 2022 Feb; 56():151846. PubMed ID: 34749048
[TBL] [Abstract][Full Text] [Related]
9. Eyelid sebaceous gland carcinoma, validation of AJCC 8th edition T staging- a retrospective study from North India.
Sen S; Bhardwaj M; Jayaraj P; Bakhshi S; Pushker N; Kashyap S; Bajaj MS; Khandpur S
Acta Ophthalmol; 2023 Feb; 101(1):49-56. PubMed ID: 35751173
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathological study in 28 cases of oral basaloid squamous cell carcinomas].
Zhou CX; Zhou Z; Zhang Y; Liu XX; Gao Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 54(1):62-67. PubMed ID: 35165469
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of Notch1 receptor and clinicopathological High-Risk Predictors in lacrimal gland adenoid cystic carcinoma.
Anjum S; Sen S; Pushker N; Bajaj MS; Kashyap S; Bakhshi S; Chosdol K; Meel R; Sharma MC
Acta Ophthalmol; 2021 Dec; 99(8):e1467-e1473. PubMed ID: 33675181
[TBL] [Abstract][Full Text] [Related]
12. Expression of metabolism-related proteins in lacrimal gland adenoid cystic carcinoma.
Koo JS; Yoon JS
Am J Clin Pathol; 2015 Apr; 143(4):584-92. PubMed ID: 25780012
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometry database of lacrimal gland adenoid cystic carcinoma and normal lacrimal gland tissue identifies extracellular matrix remodeling in these tumors.
Moeyersoms AHM; Stathias V; Doddapaneni R; Tse DT; Pelaez D
Data Brief; 2023 Aug; 49():109330. PubMed ID: 37409171
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes of eye-sparing surgery for adenoid cystic carcinoma of lacrimal gland.
Hung JY; Wei YH; Huang CH; Chen LW; Fuh CS; Liao SL
Jpn J Ophthalmol; 2019 Jul; 63(4):344-351. PubMed ID: 31134459
[TBL] [Abstract][Full Text] [Related]
15. Differences in clinical features and prognosis between orbit adenoid cystic carcinoma and adenocarcinoma: a study from the SEER 18 database.
Liu R; Li J; Zhang X; Ge X; Ma J
Tumori; 2023 Feb; 109(1):61-70. PubMed ID: 35114870
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery.
Jeong IS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY
J Cancer Res Clin Oncol; 2020 May; 146(5):1343-1350. PubMed ID: 32144535
[TBL] [Abstract][Full Text] [Related]
17. Spatial Transcriptomics Identifies Expression Signatures Specific to Lacrimal Gland Adenoid Cystic Carcinoma Cells.
Moeyersoms AHM; Gallo RA; Zhang MG; Stathias V; Maeng MM; Owens D; Abou Khzam R; Sayegh Y; Maza C; Dubovy SR; Tse DT; Pelaez D
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370820
[TBL] [Abstract][Full Text] [Related]
18. Disappearance of primitive basaloid cells after external irradiation in adenoid cystic carcinoma of the lacrimal gland.
Tirakunwichcha S; Tulvatana W
J Med Assoc Thai; 2006 Aug; 89(8):1318-21. PubMed ID: 17048448
[TBL] [Abstract][Full Text] [Related]
19. Predictors of Outcome in Mammary Adenoid Cystic Carcinoma: A Multi-Institutional Study.
Slodkowska E; Xu B; Kos Z; Bane A; Barnard M; Zubovits J; Iyengar P; Faragalla H; Turbin D; Williams P; Barnes PJ; Mulligan AM
Am J Surg Pathol; 2020 Feb; 44(2):214-223. PubMed ID: 31567278
[TBL] [Abstract][Full Text] [Related]
20. [Imaging feature and clinical histological analysis of 12 adenoid cystic carcinoma of the lacrimal gland].
Wang F; Sun FY; Guo XX; Xia S; Tang DR
Zhonghua Yan Ke Za Zhi; 2013 Jan; 49(1):47-51. PubMed ID: 23601466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
